NCT00313794 - Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Colorectal Neoplasms

Interventions

DRUG

CP-675,206

15 mg/kg IV q 3 months for 4 cycles in the absence of disease progression or unacceptable toxicity.

Trial Locations (11)

Research Site, New York

Research Site, Bessemer

Research Site, Birmingham

Research Site, Birmingham

Research Site, Birmingham

Research Site, Birmingham

Research Site, Birmingham

Research Site, San Francisco

Research Site, San Francisco

Research Site, Lévis

Research Site, Québec